Neuroprotective effect of lutein against 3-nitropropionic acid-induced huntington's disease-like symptoms: Possible behavioral, biochemical, and cellular alterations

Journal of Medicinal Food

Volumn 16, Issue 10, 2013, Pages 934-943

  Binawade, Yogita ^a   Jagtap, Aarti ^a  

^a BOMBAY COLLEGE OF PHARMACY   (India)

Author keywords

antioxidant activity; in vivo; mitochondria; neurodegenerative disease; oxidative stress

Indexed keywords

3 NITROPROPIONIC ACID; ACETYLCHOLINESTERASE; CATALASE; GLUTATHIONE; MITOCHONDRIAL ENZYME; NITRITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); XANTHOPHYLL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BODY WEIGHT; BRAIN MITOCHONDRION; CHEMICAL ANALYSIS; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; FEMALE; GLIOSIS; HISTOPATHOLOGY; HUNTINGTON DISEASE LIKE SYNDROME; LIPID BRAIN LEVEL; LIPID PEROXIDATION; LOCOMOTION; MAZE TEST; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RESPIRATORY CHAIN; SPATIAL MEMORY; SWELLING; WEIGHT REDUCTION;

ANIMALS; BRAIN; FEMALE; GLUTATHIONE; HUMANS; HUNTINGTON DISEASE; LIPID PEROXIDATION; LUTEIN; MAZE LEARNING; MEMORY; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; NITRO COMPOUNDS; PROPIONATES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84886078963     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2012.2698     Document Type: Article

References (48)

1. Ramaswamy S, McBride JL, Kordower JH, et al.: Animal models of Huntingtons disease. ILAR J 2007;48:356-373.
2. Wang LH, Qin ZH: Animal models of Huntingtons disease: implications in uncovering pathogenic mechanisms and developing therapies. Acta Pharmacol Sin 2006;27:1287-1302.
3. Garcia M, Vanhoutte P, Pages C, et al.: The mitochondrial toxin 3-nitropropionic acid induces striatal neurodegeneration via a c-Jun N-terminal kinase/c-Jun module. J Neurosci 2002;22: 2174-2184.
4. Kumar P, Kalonia H, Kumar A: Huntingtons disease: pathogenesis to animal models. Pharmacol Rep 2010;62:1-14.
5. Puneet K, Padi SSV, Naidu PSAND, Kumar A: 3-Nitropropionic acid induced neurotoxicity: an animal model of Huntingtons disease. J Cell Tissue Res 2007;7:853-860.
6. Beal MF, Chirichigno JW, Augood SJ, et al.: Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 1993;13:4181-4192.
7. Sen S, Raja Chakraborty C. Sridhar, et al.: Free radicals, antioxidants, disease and phytomedicines: current status and future prospect. Int J Pharmaceut Sci Rev Res 2010;3:Article 021.
8. Wang M, Tsao R, Zhang S, et al.: Antioxidant activity, mutagenicity/anti-mutagenicity, and clastogenicity/anti-clastogenicity of lutein from marigold flowers. Food Chem Toxicol 2006;54: 7998-8005.
9. Miki W: Biological functions and activities of animal carotenoids. Pure Appl Chem 1991;63:141-146.
10. Mozaffarieh M, Sacu S, Wedrich A: The role of the carotenoids, lutein and zeaxanthin, in protecting against age-related macular degeneration: a review based on controversial evidence. Nutr J 2003;2:20-24.
11. Lee DH, Kim CS, Lee YJ: Astaxanthin protects against MPTP/MPP + -induced mitochondrial dysfunction and ROS production in vivo and in vitro. Food Chem Toxicol 2001;49:271-280.
12. Wang W, Shinto L, Connor WE, Quinn JF: Nutritional biomarkers in Alzheimers disease: the association between carotenoids, n-3 fatty acids, and dementia severity. J Alzheimers Dis 2008;13:31-38.
13. Allbutt HN, Henderson JM: Use of the Narrow Beam test in the rat, 6-hydroxydopamine model of Parkinsons disease. J Neurosci Methods 2007;159:195-202.
14. Kumar A, Dorga S, Prakash A: Protective effect of curcumin, against aluminium toxicity: possible behavioral and biochemical alterations in rats. Behav Brain Res 2005;205:384-390.
15. Reddy DS, Kulkarni SK: Possible role of nitric oxide in the nootropic and anti-Amnesic effects of neurosteroids on aging and dizociline induced leaning impairment. Brain Res 1998;799:215-219.
16. Sandhir R, Mehrotra A, Kamboj SS: Lycopene prevents 3- nitropropionic acid-induced mitochondrial oxidative stress and dysfunctions in nervous system. Neurochem Int 2010;57:579-587.
17. King TE, Howard RL: Preparations and properties of soluble NADH dehydrogenases from cardiac muscle. Methods Enzymol 1967;10:275-294.
18. King TE: Preparation of succinate dehydrogenase and reconstitution of succinate oxidase. Methods Enzymol 1967;10:322-331.
19. Sottocasa GL, Kuylenstierna B, Ernster L, Bergstrand A: An electron-transport system associated with the outer membrane of liver mitochondria: a biochemical and morphological study. J Cell Biol 1967;32:415-438.
20. Kamboj SS, Kumar V, Kamboj A, Sandhir R: Mitochondrial oxidative stress and dysfunction in rat brain induced by carbofuran exposure. Cell Mol Neurobiol 2008;28:961-969.
21. Ohkawa H, Ohini N, Yogi K: Assay of lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95: 351-358.
22. Luck H: Catalase. In: Methods of Enzymatic Analysis (Bergmeyer HU, ed.). Academic Press, New York, 1971, pp. 885-893.
23. Ellman GL: Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70-77.
24. Green LC, Wagner DA, Glogowski J, et al.: Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 1982;126:131-138.
25. Ellman GL, Courtney KD, Andres V Jr., Feather-Stone RM: New and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharamcol 1961;7:88-95.
26. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265.
27. Hartz JS: Simultaneous histologic fixation and gross determination of calcification. Am J Clin Pathol 1974;17:750-753.
28. Browne SE, Bowling AC, MacGarvey U, et al.: Oxidative damage and metabolic dysfunction in Huntingtons disease: selective vulnerability of the basal ganglia. Ann Neurol 1997;41:646-653.
29. Kumar P, Kumar A: Effect of lycopene and epigallocatechin-3- gallate against 3-nitropropionic acid induced cognitive dysfunction and glutathione depletion in rat: A novel nitric oxide mechanism. Food Chem Toxicol 2009;47:2522-2530.
30. Kumar P, Kumar A: Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntingtons disease. J Med Food 2009;12: 591-600.
31. Lagoa R, Lopez-Sanchez C, Samhan-Arias AK, Ganan CM, Garcia-Martinez V, Gutierrez-Merino C: Kaempferol protects against rat striatal degeneration induced by 3-nitropropionic acid. J Neurochem 2009;111:473-487.
32. Kumar P, Kumar A: Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntingtons like symptoms in rats: possible role of nitric oxide. Behav Brain Res 2010;206:38-46.
33. Kumar P, Kumar A: Possible role of sertraline against 3- nitropropionic acid induced behavioral, oxidative stress and mitochondrial dysfunctions in rat brain. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:100-108.
34. Santamaria A, Ali SF: Protective effect of S-Allylcysteine on 3- nitropropionic acid induced lipid peroxidation and mitochondrial dysfunction in rat brain synaptosomes. Brain Res Bull 2006;68: 379-383.
35. Binienda ZK, Ali SA: Neuroprotective role of L-carnitine in the 3-nitropropionic acid induced neurotoxicity. Toxicol Lett 2001; 125:67-73.
36. Tadros MG, Khalifa AE, Abdel-Naim AB, Arafa HM: Neuroprotective effect of taurine in 3-nitropropionic acid-induced experimental animal model of Huntingtons disease phenotype. Pharmacol Biochem Behav 2005;82:574-582.
37. Kumar P, Padi SS, Naidu PS, Kumar A: Effect of resveratrol on 3-nitropropionic acid-induced biochemical and behavioral changes: possible neuroprotective mechanisms. Behav Pharmacol 2006;17:485-492.
38. Saydoff JA, Liu LS, Garcia RA, Hu Z, Li D, Borstel RW: Oral uridine pro-drug PN401 decreases neurodegeneration, behavioral impairment, weight loss and mortality in the 3-nitropropionic acid mitochondrial toxin model of Huntingtons disease. Brain Res 2003;994:44-54.
39. Silva RH, Ab?́lio VC, Kameda SR, et al.: Effects of 3-nitropropionic acid administration on memory and hippocampal lipid peroxidation in sleep-deprived mice. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:65-70.
40. Lee WT, Chang C: Magnetic resonance imaging and spectroscopy in assessing 3-nitropropionic acid-induced brain lesions: an animal model of Huntingtons disease. Prog Neurobiol 2004;72: 87-110.
41. Beal MF: Mitochondrial dysfunction in neurodegenerative diseases. Biochim Biophys Acta 1998;1366:211-223.
42. Túnez I, Munoz MC, Feijóo M, et al.: Protective melatonin effect on oxidative stress induced by okadaic acid into rat brain. J Pineal Res 2003;34:265-268.
43. Villarán RF, Tomás-Camardiel M, de Pablos RM, et al.: Endogenous dopamine enhances the neurotoxicity of 3-nitropropionic acid in the striatum through the increase of mitochondrial respiratory inhibition and free radicals production. Neurotoxicology 2008;29:244-258.
44. McGeer PL, McGeer EG, Fibiger HC: Choline acetylase and glutamic acid decarboxylase in Huntingtons chorea: a preliminary study. Neurology 1973;9:912-917.
45. Sharma M, Sharma N, Sharma R: Neuroprotective effect of Zingiber officinale in 3-NP-induced Huntington disease. IOSR J Pharm 2012;2:61-70.
46. Abe K, Saito H: Amyloid b protein inhibits cellular MTT reduction not by suppression of mitochondrial succinate dehydrogenase but by acceleration of MTT formazan exocytosis in cultured rat cortical astrocytes. Neurosci Res 1998;31:295-305.
47. Warltier DC: Clinical implications of mitochondrial dysfunction. Anesthesiology 2006;105:819-837.
48. Nicholls DG, Budd SL: Mitochondria and neuronal survival. Physiol Rev 2000;80:315-360.